Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging

European Journal of Radiology

Volumn 81, Issue 7, 2012, Pages 1460-1464

  Katsube, Takashi ^a   Okada, Masahiro ^b   Kumano, Seishi ^b   Imaoka, Izumi ^b   Kagawa, Yuki ^b   Hori, Masatoshi ^c   Ishii, Kazunari ^b   Tanigawa, Noboru ^d   Imai, Yasuharu ^e   Kudo, Masatoshi ^b   Murakami, Takamichi ^b  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^e IKEDA MUNICIPAL HOSPITAL   (Japan)

Author keywords

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd EOB DTPA); Liver function; mapping; T2*

Indexed keywords

GADOXETIC ACID;

AGED; ARTICLE; CHILD PUGH SCORE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; LIVER FUNCTION; LIVER MUSCLE SIGNAL INTENSITY RATIO; LIVER SCINTISCANNING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SCORING SYSTEM;

AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 84861583342     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.03.073     Document Type: Article

References (20)

1. J.E. Juni, and R. Reichle Measurement of hepatocellular function with deconvolutional analysis: application in the differential diagnosis of acute jaundice Radiology 177 1 1990 171 175
2. A.H. Kwon, S.K. Ha-Kawa, and S. Uetsuji Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy Hepatology 25 2 1997 426 429
3. A. Tanimoto, Y. Yuasa, and H. Shinmoto Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function Radiology 222 3 2002 661 666
4. Y. Yamashita, H. Yamamoto, A. Hirai, S. Yoshimatsu, Y. Baba, and M. Takahashi MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: influence of liver dysfunction and parenchymal pathology Abdom Imaging 21 4 1996 318 323
5. T. Murakami, T. Kim, and M. Takamura Evaluation of regional liver damage by magnetic resonance imaging with superparamagnetic iron oxide in rat liver Dig Dis Sci 46 1 2001 148 155
6. G. Schuhmann-Giampieri, H. Schmitt-Willich, and W.R. Press Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system Radiology 183 1 1992 59 64
7. B. Hamm, T. Staks, and A. Mühler Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 3 1995 785 792
8. K. Saito, H. Shindo, and T. Ozuki Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase Magn Reson Med Sci 4 1 2005 1 9
9. M. Fujita, R. Yamamoto, and B. Fritz-Zieroth Contrast enhancement with Gd-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide J Magn Reson Imaging 6 3 1996 472 477
10. N. Tsuda, M. Okada, and T. Murakami Potential of gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging Invest Radiol 42 4 2007 242 247
11. J. Shimizu, K. Dono, and M. Gotoh Evaluation of regional liver function by gadolinium-EOB-DTPA-enhanced MR imaging Dig Dis Sci 44 7 1999 1330 1337
12. S.A. Schmitz, A. Mühler, S. Wagner, and K.J. Wolf Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats Invest Radiol 31 3 1996 154 160
13. T. Kim, T. Murakami, and Y. Hasuike Experimental hepatic dysfunction: evaluation by MRI with Gd-EOB-DTPA J Magn Reson Imaging 7 4 1997 683 688
14. H. Dahnke, and T. Schaeffter Limits of detection of SPIO at 3.0 T using T2 relaxometry Magn Reson Med 53 5 2005 1202 1206
15. U. Motosugi, T. Ichikawa, and H. Sou Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 30 5 2009 1042 1046
16. L. Pascolo, F. Cupelli, and P.L. Anelli Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents Biochem Biophys Res Commun 257 3 1999 746 752
17. J.E. van Montfoort, B. Stieger, D.K. Meijer, H.J. Weinmann, P.J. Meier, and K.E. Fattinger Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1 J Pharmacol Exp Ther 290 1 1999 153 157
18. A. Geier, S.K. Kim, and T. Gerloff Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride J Hepatol 37 2 2002 198 205
19. C. Planchamp, X. Montet, and J.L. Frossard Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers Invest Radiol 40 4 2005 187 194
20. P. Reimer, E.J. Rummeny, and K. Shamsi Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence Radiology 199 1 1996 177 183